- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
Total 19552 results
-
Shengjing HospitalNot yet recruiting
-
Jonsson Comprehensive Cancer CenterParker Institute for Cancer Immunotherapy; California Institute for Regenerative... and other collaboratorsRecruitingMelanoma | Breast Cancer | Neuroendocrine Tumors | Lung Adenocarcinoma | Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma | Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Uveal Melanoma | Paraganglioma | Adrenocortical Carcinoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Acral Melanoma | Cutaneous... and other conditionsUnited States
-
Hasselt UniversityJessa HospitalRecruitingBreast Cancer | Alopecia | Chemotherapy-induced AlopeciaBelgium
-
European Institute of OncologyNot yet recruitingBreast Cancer | Chest Wall Tumor
-
Fudan UniversityRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
UMC UtrechtCenter for Translational Molecular Medicine; Dutch Cancer Society; Vrienden UMC...RecruitingBreast Cancer | Breast Neoplasms | Metastatic Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Invasive Ductal Breast Cancer | Invasive Ductal Carcinoma of Female Breast | Adenocarcinoma BreastNetherlands
-
Institut Paoli-CalmettesMSD France; OncodistinctRecruitingInflammatory Breast CancerFrance, Belgium
-
National Cancer Center, KoreaRecruitingBreast Cancer | Invasive Breast CancerKorea, Republic of
-
National Cancer Institute (NCI)RecruitingBreast Cancer | Multiple Myeloma | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Gastrointestinal/Genitourinary Cancers | Endocrine TumorsUnited States
-
NSABP Foundation IncGenentech, Inc.; Celcuity, LLCRecruitingHER2-negative Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Shi YanxiaRecruitingBreast Cancer | Effects of Chemotherapy | Breast Cancer ModelChina
-
Shanghai Jiao Tong University School of MedicineShanghai 10th People's Hospital; China-Japan Union Hospital, Jilin University; Ganzhou City People's HospitalRecruiting
-
National Cancer Institute (NCI)RecruitingMelanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Renal Cell CancerUnited States
-
Institut BergoniéMerck Sharp & Dohme LLC; National Cancer Institute, France; Transgene; Fondation...RecruitingBreast Cancer | Soft-tissue Sarcoma | Solid TumorsFrance
-
Shandong UniversityRecruiting
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
National Cancer Institute (NCI)RecruitingMetastatic Colorectal Cancer | Metastatic Pancreatic Cancer | Metastatic Breast Carcinoma | Metastatic Ovarian Cancer | Metastatic Endocrine Tumors/ Neuroendocrine TumorsUnited States
-
Lucia Del Mastro,MDCompleted
-
National Cancer Institute (NCI)WithdrawnT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
IRCCS Azienda Ospedaliera Universitaria San Martino...Gruppo Italiano Mammella (GIM)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.Active, not recruitingMalignant Solid Neoplasm | Soft Tissue Sarcoma | Recurrent Ovarian Carcinoma | Triple Negative Breast Cancer | Recurrent Osteosarcoma | Refractory Osteosarcoma | Bone Sarcoma | Giant Cell Tumor of Bone | Ovarian Carcinosarcoma | Platinum-Resistant Ovarian Carcinoma | Dedifferentiated Chondrosarcoma | Malignancy... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Ph-Like Acute Lymphoblastic Leukemia | Refractory Ph-Like Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
National Cancer Institute (NCI)Active, not recruitingRhabdomyosarcoma | Alveolar Rhabdomyosarcoma | Embryonal Rhabdomyosarcoma | Botryoid-Type Embryonal Rhabdomyosarcoma | Sclerosing Rhabdomyosarcoma | Spindle Cell RhabdomyosarcomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Bellicum PharmaceuticalsActive, not recruitingBreast Cancer | Lung Cancer | Mesothelioma | Metastases | Malignant Pleural DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)SuspendedB Acute Lymphoblastic LeukemiaUnited States, Canada
-
Sun Yat-sen UniversityCompleted
-
Dana-Farber Cancer InstituteIncyte CorporationActive, not recruitingInflammatory Breast Cancer (IBC)United States
-
Palleos Healthcare GmbHRoche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUPCompleted
-
Henan Cancer HospitalCompletedTriple Negative Breast CancerChina
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingS0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerBreast CancerUnited States, Puerto Rico, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupActive, not recruitingBreast CancerUnited States, Belgium, Canada, Australia, Austria, Bulgaria, China, Croatia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Panama, Slovenia, Spain, Taiwan, United Kingdom, Colombia, Czechia, El Salvador and more
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; North Central...Active, not recruitingBreast AdenocarcinomaUnited States, Peru, South Africa
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
National Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Ann Arbor Stage II Non-Hodgkin LymphomaUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in the Bone | Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | Metastatic Malignant Neoplasm in the Lung | Metastatic Ewing Sarcoma | Metastatic Malignant Neoplasm in the Bone Marrow | Metastatic Peripheral Primitive Neuroectodermal Tumor of BoneUnited States, Canada, Puerto Rico
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheActive, not recruiting
-
Mansoura UniversityActive, not recruiting